September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Intravenously Administered Neostigmine Combined with Prism and Alternate Cover Test as a Diagnostic Test for Myasthenia Gravis with ocular involvement
Author Affiliations & Notes
  • Dong Ik Kim
    Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Byung Joo Lee
    Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Seong-Joon Kim
    Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Dong Ik Kim, None; Byung Joo Lee, None; Seong-Joon Kim, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5993. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Dong Ik Kim, Byung Joo Lee, Seong-Joon Kim; Intravenously Administered Neostigmine Combined with Prism and Alternate Cover Test as a Diagnostic Test for Myasthenia Gravis with ocular involvement. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5993.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To address the validity of intravenous neostigmine administration combined with prism and alternate cover test (PACT) measurement as a confirmatory diagnostic method for confusing cases of myasthenia gravis with ocular involvement.

Methods : Neostigmine was administered intravenously in ten suspicious myasthenic diplopia patients under electrocardiographic monitoring. Distance deviation at primary position was evaluated with PACT at 5, 10, 15, 20 and 30 minutes after intravenous injection of neostigmine. Margin reflex distance and range of duction were also evaluated at each time points.

Results : 7 out of 21 patients were diagnosed as myasthenic diplopia by positive neostigmine test. Among these patients, everyone had abnormal ocular motility and 5 had ptosis. In participants who showed positive result, impairment of ocular motility was relieved invariably, but ptosis was not improved in one patient. The improvement of ocular motility had been occurred within 5 minutes in all 7 responders and the pharmacological effect reached peak at 5 to 20 minutes (mean: 13 minutes) after neostigmine administration.

Conclusions : Intravenous neostigmine administration combined with PACT is a rapid, objective and quantifiable method in hard-to-diagnose cases of myasthenia gravis with ocular involvement. In performing neostigmine test for myasthenia gravis with ocular involvement, not only the lid position, but also ocular motility should be evaluated quantitatively to avoid a false negative result.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×